HFE mutations in idiopathic dilated cardiomyopathy.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Medizinische Klinik

• Publication date

  2006-03-22

• Fields of study

  Medicine

• Identifiers
  PMID 16802538
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report--2004.

  2004cited by this paper
• Hereditary hemochromatosis--a new look at an old disease.

  2004cited by this paper
• Non‐HFE hemochromatosis

  2004cited by this paper
• The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult lung and heart-lung transplant report--2004.

  2004cited by this paper
• Hemochromatosis mutations are not linked to dilated cardiomyopathy in Israeli patients.

  2003cited by this paper
• Hfe deficiency increases susceptibility to cardiotoxicity and exacerbates changes in iron metabolism induced by doxorubicin.

  2003cited by this paper
• Haemochromatosis (HFE) gene C282Y mutation and the risk of coronary artery disease and myocardial infarction: a study in 1279 patients undergoing coronary angiography

  2003cited by this paper
• HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.

  2003cited by this paper
• Genetics of familial cardiomyopathies and arrhythmias.

  2002cited by this paper
• Body iron stores and coronary heart disease.

  2002cited by this paper
• Hemochromatosis gene variants in patients with cardiomyopathy.

  2001cited by this paper
• Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study.

  2001cited by this paper
• The major histocompatibility complex-encoded HFE in iron homeostasis and immune function

  2000cited by this paper
• Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy

  2000cited by this paper
• Guidelines for the study of familial dilated cardiomyopathies. Collaborative Research Group of the European Human and Capital Mobility Project on Familial Dilated Cardiomyopathy.

  1999cited by this paper
• Global prevalence of putative haemochromatosis mutations.

  1997cited by this paper
• A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis

  1996cited by this paper
• Long-term survival in patients with hereditary hemochromatosis.

  1996cited by this paper
• Molecular and clinical aspects of inherited cardiomyopathies.

  1995cited by this paper
• Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis.

  1985cited by this paper

• Cardiac Magnetic Resonance at 3.0 T in Patients With C282Y Homozygous Hereditary Hemochromatosis

  2022cites this paper
• Possible Susceptibility Genes for Intervention against Chemotherapy-Induced Cardiotoxicity

  2020cites this paper
• Translating emerging molecular genetic insights into clinical practice in inherited cardiomyopathies

  2018cites this paper
• Hereditary Juvenile Haemochromatosis and Idiopathic Dilated Cardiomyopathy

  2015cites this paper
• Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia

  2013cites this paper
• Genetic testing for inherited cardiac disease

  2013cites this paper
• Risk Factors and Event Rates in Patients With Atherothrombotic Disease in Germany: Results of the REACH Registry.

  2008cites this paper